Drug and Gene Delivery Devices Market Size, Trends, Analysis, and Outlook By Route of Administration (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Method (In situ, Ex vivo), by Region, Country, Segment, and Companies, 2024-2030
The global Drug and Gene Delivery Devices market size is poised to register 7.51% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Drug and Gene Delivery Devices market across By Route of Administration (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Method (In situ, Ex vivo).
The drug and gene delivery devices market is projected to see notable growth, driven by increasing demand for targeted drug delivery systems, nucleic acid delivery platforms, and gene editing technologies in pharmaceutical research, biotechnology innovation, and gene therapy applications, along with advancements in drug delivery formulations, biomaterials, and nanotechnology. With a focus on enhancing therapeutic efficacy, minimizing off-target effects, and overcoming biological barriers, researchers and drug developers are utilizing drug and gene delivery devices such as liposomes, nanoparticles, viral vectors, and gene editing tools for delivering small molecule drugs, biologics, and nucleic acids to specific tissues and cells. Additionally, expanding applications in regenerative medicine, immuno-oncology, and genetic diseases, along with growing investment in drug delivery technology startups and academic research collaborations, are driving market expansion as stakeholders seek to unlock the potential of precision medicine, gene therapy, and personalized healthcare solutions for improving patient outcomes and addressing unmet medical needs.
Drug and Gene Delivery Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug and Gene Delivery Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug and Gene Delivery Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug and Gene Delivery Devices industry.
Key market trends defining the global Drug and Gene Delivery Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug and Gene Delivery Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Drug and Gene Delivery Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug and Gene Delivery Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug and Gene Delivery Devices industry
Leading Drug and Gene Delivery Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug and Gene Delivery Devices companies.
Drug and Gene Delivery Devices Market Study- Strategic Analysis Review
The Drug and Gene Delivery Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Drug and Gene Delivery Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Drug and Gene Delivery Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Drug and Gene Delivery Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Drug and Gene Delivery Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Drug and Gene Delivery Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Drug and Gene Delivery Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug and Gene Delivery Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug and Gene Delivery Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Drug and Gene Delivery Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug and Gene Delivery Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug and Gene Delivery Devices in Asia Pacific. In particular, China, India, and South East Asian Drug and Gene Delivery Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Drug and Gene Delivery Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug and Gene Delivery Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug and Gene Delivery Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug and Gene Delivery Devices.
Drug and Gene Delivery Devices Market Company Profiles
The global Drug and Gene Delivery Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, Bausch & Lomb Inc, Becton Dickinson and Company, Bluebird bio Inc, Castle Creek Biosciences Inc, Dendreon Pharmaceuticals, Helixmith Co. Ltd, Human Stem Cell Institute, Kite Pharma Inc, Kolon Tissue Gene Inc, Novartis AG, Orchard Therapeutics plc, Pfizer Inc, Renova Therapeutics, Spark Therapeutics Inc, uniQure N.V., Vericel Corp, ViroMed Co. Ltd
Recent Drug and Gene Delivery Devices Market Developments
The global Drug and Gene Delivery Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug and Gene Delivery Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Route of Administration
Oral
Inhalation
Transdermal
Injectable
Ocular
Nasal
Topical
By Gene Delivery Vector
Viral
Non-viral
By Method
In situ
Ex vivo
Geographical Segmentation:
Amgen Inc
Bausch & Lomb Inc
Becton Dickinson and Company
Bluebird bio Inc
Castle Creek Biosciences Inc
Dendreon Pharmaceuticals
Helixmith Co. Ltd
Human Stem Cell Institute
Kite Pharma Inc
Kolon Tissue Gene Inc
Novartis AG
Orchard Therapeutics plc
Pfizer Inc
Renova Therapeutics
Spark Therapeutics Inc
uniQure N.V.
Vericel Corp
ViroMed Co. Ltd
Formats Available: Excel, PDF, and PPT
The drug and gene delivery devices market is projected to see notable growth, driven by increasing demand for targeted drug delivery systems, nucleic acid delivery platforms, and gene editing technologies in pharmaceutical research, biotechnology innovation, and gene therapy applications, along with advancements in drug delivery formulations, biomaterials, and nanotechnology. With a focus on enhancing therapeutic efficacy, minimizing off-target effects, and overcoming biological barriers, researchers and drug developers are utilizing drug and gene delivery devices such as liposomes, nanoparticles, viral vectors, and gene editing tools for delivering small molecule drugs, biologics, and nucleic acids to specific tissues and cells. Additionally, expanding applications in regenerative medicine, immuno-oncology, and genetic diseases, along with growing investment in drug delivery technology startups and academic research collaborations, are driving market expansion as stakeholders seek to unlock the potential of precision medicine, gene therapy, and personalized healthcare solutions for improving patient outcomes and addressing unmet medical needs.
Drug and Gene Delivery Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Drug and Gene Delivery Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Drug and Gene Delivery Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Drug and Gene Delivery Devices industry.
Key market trends defining the global Drug and Gene Delivery Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Drug and Gene Delivery Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Drug and Gene Delivery Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Drug and Gene Delivery Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Drug and Gene Delivery Devices industry
Leading Drug and Gene Delivery Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Drug and Gene Delivery Devices companies.
Drug and Gene Delivery Devices Market Study- Strategic Analysis Review
The Drug and Gene Delivery Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Drug and Gene Delivery Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Drug and Gene Delivery Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Drug and Gene Delivery Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Drug and Gene Delivery Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Drug and Gene Delivery Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Drug and Gene Delivery Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Drug and Gene Delivery Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Drug and Gene Delivery Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Drug and Gene Delivery Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Drug and Gene Delivery Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Drug and Gene Delivery Devices in Asia Pacific. In particular, China, India, and South East Asian Drug and Gene Delivery Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Drug and Gene Delivery Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Drug and Gene Delivery Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Drug and Gene Delivery Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Drug and Gene Delivery Devices.
Drug and Gene Delivery Devices Market Company Profiles
The global Drug and Gene Delivery Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, Bausch & Lomb Inc, Becton Dickinson and Company, Bluebird bio Inc, Castle Creek Biosciences Inc, Dendreon Pharmaceuticals, Helixmith Co. Ltd, Human Stem Cell Institute, Kite Pharma Inc, Kolon Tissue Gene Inc, Novartis AG, Orchard Therapeutics plc, Pfizer Inc, Renova Therapeutics, Spark Therapeutics Inc, uniQure N.V., Vericel Corp, ViroMed Co. Ltd
Recent Drug and Gene Delivery Devices Market Developments
The global Drug and Gene Delivery Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Drug and Gene Delivery Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Route of Administration
Oral
Inhalation
Transdermal
Injectable
Ocular
Nasal
Topical
By Gene Delivery Vector
Viral
Non-viral
By Method
In situ
Ex vivo
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Amgen Inc
Bausch & Lomb Inc
Becton Dickinson and Company
Bluebird bio Inc
Castle Creek Biosciences Inc
Dendreon Pharmaceuticals
Helixmith Co. Ltd
Human Stem Cell Institute
Kite Pharma Inc
Kolon Tissue Gene Inc
Novartis AG
Orchard Therapeutics plc
Pfizer Inc
Renova Therapeutics
Spark Therapeutics Inc
uniQure N.V.
Vericel Corp
ViroMed Co. Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Drug and Gene Delivery Devices Market Overview and Key Findings, 2024
1.2 Drug and Gene Delivery Devices Market Size and Growth Outlook, 2021- 2030
1.3 Drug and Gene Delivery Devices Market Growth Opportunities to 2030
1.4 Key Drug and Gene Delivery Devices Market Trends and Challenges
1.4.1 Drug and Gene Delivery Devices Market Drivers and Trends
1.4.2 Drug and Gene Delivery Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug and Gene Delivery Devices Companies
2. DRUG AND GENE DELIVERY DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Drug and Gene Delivery Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Drug and Gene Delivery Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG AND GENE DELIVERY DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG AND GENE DELIVERY DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Route of Administration
Oral
Inhalation
Transdermal
Injectable
Ocular
Nasal
Topical
By Gene Delivery Vector
Viral
Non-viral
By Method
In situ
Ex vivo
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug and Gene Delivery Devices Market, 2025
5.2 Asia Pacific Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug and Gene Delivery Devices Market, 2025
5.5 Europe Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug and Gene Delivery Devices Market, 2025
5.8 North America Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug and Gene Delivery Devices Market, 2025
5.11 South America Pacific Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug and Gene Delivery Devices Market, 2025
5.14 Middle East Africa Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug and Gene Delivery Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug and Gene Delivery Devices Industry Drivers and Opportunities
7. DRUG AND GENE DELIVERY DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG AND GENE DELIVERY DEVICES COMPANY PROFILES
8.1 Profiles of Leading Drug and Gene Delivery Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
Bausch & Lomb Inc
Becton Dickinson and Company
Bluebird bio Inc
Castle Creek Biosciences Inc
Dendreon Pharmaceuticals
Helixmith Co. Ltd
Human Stem Cell Institute
Kite Pharma Inc
Kolon Tissue Gene Inc
Novartis AG
Orchard Therapeutics plc
Pfizer Inc
Renova Therapeutics
Spark Therapeutics Inc
uniQure N.V.
Vericel Corp
ViroMed Co. Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Drug and Gene Delivery Devices Market Overview and Key Findings, 2024
1.2 Drug and Gene Delivery Devices Market Size and Growth Outlook, 2021- 2030
1.3 Drug and Gene Delivery Devices Market Growth Opportunities to 2030
1.4 Key Drug and Gene Delivery Devices Market Trends and Challenges
1.4.1 Drug and Gene Delivery Devices Market Drivers and Trends
1.4.2 Drug and Gene Delivery Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Drug and Gene Delivery Devices Companies
2. DRUG AND GENE DELIVERY DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Drug and Gene Delivery Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Drug and Gene Delivery Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. DRUG AND GENE DELIVERY DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. DRUG AND GENE DELIVERY DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Route of Administration
Oral
Inhalation
Transdermal
Injectable
Ocular
Nasal
Topical
By Gene Delivery Vector
Viral
Non-viral
By Method
In situ
Ex vivo
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Drug and Gene Delivery Devices Market, 2025
5.2 Asia Pacific Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Drug and Gene Delivery Devices Market, 2025
5.5 Europe Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Drug and Gene Delivery Devices Market, 2025
5.8 North America Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Drug and Gene Delivery Devices Market, 2025
5.11 South America Pacific Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Drug and Gene Delivery Devices Market, 2025
5.14 Middle East Africa Drug and Gene Delivery Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Drug and Gene Delivery Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Drug and Gene Delivery Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Drug and Gene Delivery Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Drug and Gene Delivery Devices Industry Drivers and Opportunities
7. DRUG AND GENE DELIVERY DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. DRUG AND GENE DELIVERY DEVICES COMPANY PROFILES
8.1 Profiles of Leading Drug and Gene Delivery Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
Bausch & Lomb Inc
Becton Dickinson and Company
Bluebird bio Inc
Castle Creek Biosciences Inc
Dendreon Pharmaceuticals
Helixmith Co. Ltd
Human Stem Cell Institute
Kite Pharma Inc
Kolon Tissue Gene Inc
Novartis AG
Orchard Therapeutics plc
Pfizer Inc
Renova Therapeutics
Spark Therapeutics Inc
uniQure N.V.
Vericel Corp
ViroMed Co. Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
